Hearing News Watch

Featured image for “MindfulTinnitusRelief.com Publishes Results of Peer-Reviewed Efficacy Study in American Journal of Audiology”
Jan. 16, 2023

MindfulTinnitusRelief.com Publishes Results of Peer-Reviewed Efficacy Study in American Journal of Audiology

HHTM
A new efficacy study concludes that an 8-week online Mindfulness Based Tinnitus Stress Reduction (i-MBTSR) program during the COVID-19 pandemic can significantly reduce tinnitus bother and long-term therapeutic results can be sustained post-treatment. Study Highlights: The average tinnitus severity rating pre-course was 59.96 (“severe tinnitus”), dropping to 44.16 (“moderate”) at mid-treatment and to 34.23 (“mild-moderate”) at course completion (as measured
Featured image for “Medicare Hearing Aid Coverage Legislation Reintroduced in US Congress”
Jan. 14, 2023

Medicare Hearing Aid Coverage Legislation Reintroduced in US Congress

HHTM
WASHINGTON, DC – Representatives Debbie Dingell (D-MI) and Brian Fitzpatrick (R-PA) have reintroduced the bipartisan Medicare Hearing Aid Coverage Act to expand Medicare to cover hearing aids for beneficiaries. Medicare does not currently cover hearing aids, which “can have an average price of about $2,500”. “Hearing aids aren’t a luxury, they are critical for millions of people to maintain a
Featured image for “Spiral Therapeutics Initiates Phase 2 Trial in Ménière’s Disease; Completes $8.25M Financing Round”
Jan. 13, 2023

Spiral Therapeutics Initiates Phase 2 Trial in Ménière’s Disease; Completes $8.25M Financing Round

HHTM
SOUTH SAN FRANCISCO, CALIFORNIA — Spiral Therapeutics, Inc., a clinical-stage company focused on delivering therapies for inner ear disorders, has announced that the company recently completed an $8.25M financing, with new proceeds that will fund the continuing development of its lead candidate, SPT-2101, for the treatment of inner ear inflammation. Existing investors Savoir Capital and Catalio Capital Management participated in this
Featured image for “New Study Links Hearing Loss With Dementia in Older Adults; Highlights Potential Benefit of Hearing Aid Use”
Jan. 11, 2023

New Study Links Hearing Loss With Dementia in Older Adults; Highlights Potential Benefit of Hearing Aid Use

HHTM
BALTIMORE, MARYLAND — A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health found that older adults with greater severity of hearing loss were more likely to have dementia, but the likelihood of dementia was lower among hearing aid users compared to non-users. The findings, from a nationally representative sample of more than 2,400 older
Featured image for “CHS Global Partnerships for Research & Innovation Awards Four Research Grants to Advance Hearing Health and Deaf Studies”
Jan. 10, 2023

CHS Global Partnerships for Research & Innovation Awards Four Research Grants to Advance Hearing Health and Deaf Studies

HHTM
TORONTO, CANADA – CHS Global Partnerships for Research & Innovation, a non-profit  organization and strategic global leader in the advancement of research and innovation that  improves the quality of life for Deaf and hard of hearing individuals, is excited to announce that it  has awarded its first four research grants – totaling $400,000 – to institutions leading research that “will
Featured image for “EUHA Announces New Guideline Implanted Hearing Systems”
Jan. 06, 2023

EUHA Announces New Guideline Implanted Hearing Systems

HHTM
After several months of intensive collaboration, the EUHA “Hearing Implants” expert group has published a new Guideline for “Implanted hearing systems in auditory acoustics”. It serves as a practical recommendation for hearing aid acousticians. People with hearing loss have many options to improve their hearing benefiting from the latest technology. For most of those affected, a hearing system fitted to
Featured image for “Sensorion Announces First Patient Enrolled in Phase 2a Clinical Trial of SENS-401 in Patients Suffering from Cisplatin-Induced Ototoxicity”
Jan. 03, 2023

Sensorion Announces First Patient Enrolled in Phase 2a Clinical Trial of SENS-401 in Patients Suffering from Cisplatin-Induced Ototoxicity

HHTM
MONTPELLIER, FRANCE — Sensorion (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announces that the first patient has been enrolled in its Phase 2a Proof of Concept clinical trial of SENS-401 (Arazasetron) in patients suffering from Cisplatin-Induced Ototoxicity. Cisplatin and
Featured image for “Passages 2022: Dr. Susan Small and Dr. David Baguley”
Dec. 31, 2022

Passages 2022: Dr. Susan Small and Dr. David Baguley

HHTM
The profession of audiology was born during World War II, and the first generation of formally educated audiologists graduated in the late 1940s. The ranks of baby boomer audiologists … born during those years and now septuagenarians are thinning due to retirement or death. Sadly, in 2022 we lost two prominent audiologists who were by any measure in the prime
Featured image for “Top Hearing News and Technology Stories of 2022”
Dec. 29, 2022

Top Hearing News and Technology Stories of 2022

HHTM
Like last year, in spite of a global pandemic, the hearing care space continued to innovate and evolve in 2022. Legislative changes, industry developments and disruptive technologies were among this year’s list of ‘most read’ hearing news and technology stories. Top Stories of 2022   1) FDA Issues Final OTC Hearing Aid Rule and PSAP Guidance In what comes as
Featured image for “Researchers Find Checkerboard-Like Arrangement of Cells in Inner Ear Vital for Hearing”
Dec. 27, 2022

Researchers Find Checkerboard-Like Arrangement of Cells in Inner Ear Vital for Hearing

HHTM
KOBE, JAPAN — A Japanese research group has become the first to reveal that the checkerboard-like arrangement of cells in the inner ear’s organ of Corti is vital for hearing. The discovery gives a new insight into how hearing works from the perspective of cell self-organization and will also enable various hearing loss disorders to be better understood. The research